Profound Medical (PROF) entered into a non-exclusive collaboration with Siemens Healthineers (SIEGY). The collaboration is aimed at laying the groundwork for Profound to begin marketing a complete therapeutics solution, combining its TULSA-PRO system with the MAGNETOM Free.Max magnetic resonance scanner from Siemens Healthineers, via Profound’s own sales force. Profound will also continue to market TULSA-PRO as a stand-alone offering, providing its customers with the flexibility to use the technology with the MR hardware of their choice. Subject to the completion of TULSA-PRO and MAGNETOM Free.Max system integration, the companies currently expect Profound to initiate sales of the combined solution in 2025.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PROF:
- Profound Medical to Release Fourth Quarter and Full Year 2023 Financial Results on March 7 – Conference Call to Follow
- Profound Medical Announces Non-Brokered Private Placement
- Profound Medical to sell 391,667 shares at $7.50 in private placement
- Profound Medical price target lowered to $12.75 from $14.25 at Alliance Global Partners
- Profound Medical sees FY23 revenue $7.1M-$7.2M, consensus $7.22M
